Emerg Infect Dis by Wieland, Ulrike et al.
1600 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 25, No. 8, August 2019
RESEARCH LETTERS
Counotte et al. systematically reviewed all available 
evidence on the risk for sexual transmission of Zika virus 
(5). Data from case reports, case series, cohort studies, in 
vitro work, and animal studies indicate that the infectious 
period for sexual transmission of Zika virus is consider-
ably shorter than the period during which viral RNA can 
be detected in semen. As a result, the World Health Or-
ganization now recommends male travelers with poten-
tial Zika virus exposure delay conception for >3 months 
rather than >6 months (6). 
In our case, Zika virus RNA might have persisted 
in semen because of failed immune clearance second-
ary to the patient’s MRH or his immunosuppressive drug 
treatment. However, when advising returning male trav-
elers in couples planning pregnancy, clinicians should 
be aware that Zika virus RNA shedding in semen might 
be intermittent and persist for longer in patients with im-
munosuppression.
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Cutavirus was previously found in cutaneous melanoma. 
We detected cutavirus DNA in only 2/185 melanoma bi-
opsies and in 0/52 melanoma metastases from patients in 
Germany. Viral DNA was localized in the upper epidermal 
layers. Swab specimens from healthy skin were cutavirus 
positive for 3.8% (9/237) of immunocompetent and 17.1% 
(35/205) of HIV-positive men.
Cutavirus, a novel human protoparvovirus with lin-ear single-stranded DNA, has been detected in fecal 
samples from children with diarrhea and in cutaneous T-
cell lymphomas (CTCL) (1,2). Recently, Mollerup et al. 
reported the identification of cutavirus in 1 of 10 cutane-
ous malignant melanomas using viral enrichment methods 
with high-throughput sequencing and real-time PCR (3). 
This discovery raised questions concerning tropism and 
pathogenicity of cutavirus in human skin. We performed 
a retrospective study to determine cutavirus DNA preva-
lence and viral load in a large collection of formalin-fixed 
paraffin-embedded tissue biopsy specimens of malignant 
melanomas and in forehead swabs of healthy skin of im-
munocompetent and HIV-positive persons in Germany.
We used 185 cutaneous malignant melanoma biopsy 
specimens from 179 patients and 52 melanoma metastases 
from 42 patients from Germany for analyses with cutavi-
rus real-time PCR (Appendix, http://wwwnc.cdc.gov/EID/
article/25/8/19-0096-App1.pdf). We detected cutavirus 
DNA only in 2 nodular malignant melanomas, located on 
the abdomen of a 64-year-old man (MM-A) and on the 
cheek of an 85-year-old woman (MM-B). Viral DNA loads 
in these biopsies were 0.3 (MM-A) and 2.8 (MM-B) cuta-
virus DNA copies per β-globin gene copy. None of the 52 
analyzed metastases carried cutavirus DNA (Table). The 
cutavirus PCR results of the 2 melanomas could be con-
firmed by sequencing and by in situ hybridization. In both 
melanomas, the cutavirus DNA–specific signals could be 
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detected only in the superficial layers and on the surface of 
the skin but not in the tumor cells (Appendix Figure).
To analyze the prevalence of cutavirus on healthy non-
lesional skin, we used 442 forehead swab specimens from 
237 immunocompetent men and 205 HIV-positive men that 
were available from a previous study (4) (Appendix). We 
found cutavirus DNA significantly more frequently on the 
skin of HIV-positive men than on the skin of healthy con-
trols (17.1% vs. 3.8%; p<0.001 by 2-sided χ2 test; Table). 
Among HIV-positive men, we found a trend for a higher 
cutavirus prevalence in patients with AIDS compared with 
those without AIDS (14/59 [23.7%; 95% CI 14.7–36.0] vs. 
19/140 [13.6%; 95% CI 8.9–20.2]; p = 0.078 by 2-sided 
χ2 test). The range of viral DNA loads found in the 44 
cutavirus-positive skin swabs was 0.004–268.75 (median 
0.41; interquartile range [IQR] 0.0–3.57); there was no sig-
nificant difference between HIV-negative and HIV-positive 
men (p = 0.389 by Mann-Whitney-U test; Table).
Mollerup et al. found cutavirus DNA in 1 of 10 mela-
nomas from Denmark and suggested investigating the role of 
cutavirus in cutaneous cancer (3). We detected cutavirus DNA 
in only 2 of 185 melanoma biopsy specimens and in none of 
52 metastases. In situ hybridization localized the viral DNA 
on the surface of the 2 cutavirus-positive melanomas and not 
within the malignant cells. Our data therefore argue against an 
oncogenic role of cutavirus in malignant melanoma.
Väisänen et al. found cutavirus DNA in 2.9% of 136 skin 
biopsy specimens from 123 organ transplant recipients and in 
none of 159 skin biopsy specimens of 98 healthy adults (5). 
In accordance with Väisänen et al., we also found cutavirus 
more frequently in immunosuppressed patients than in healthy 
(immunocompetent) adults. Their finding related to healthy 
adults is in contrast to our results; however, we analyzed 
not skin biopsy specimens but widespread skin swab speci-
mens covering ≈10 cm2 of forehead skin (4). Our cutavirus 
DNA prevalence data on normal skin of immunocompetent 
adults (3.8%) are in line with cutavirus IgG seroprevalence 
rates reported for adults in Finland, Iran, and Kenya (4.2%–
5.6%). Lower cutavirus IgG seroprevalence rates have been 
found in the United States (0%) and Iraq (1%) (6).
A pathogenic role of cutavirus has been investigated 
in further malignancies. Concerning CTCL, conflicting re-
sults have been reported. Phan et al. have found cutavirus 
DNA in 23.5% (4/17) (1) and Väisänen et al. in 16% (4/25) 
of CTCL of the mycosis fungoides type (5). Our group re-
cently analyzed 189 biopsies of various cutaneous B- and 
T-cell lymphoma types and detected cutavirus DNA only 
in 5.8% of 104 mycosis fungoides biopsy specimens (7). 
In contrast, Bergallo et al. could not detect cutavirus in 55 
CTCL samples (8). The in situ hybridization results of a 
cutavirus-positive mycosis fungoides sample analyzed by 
Phan et al. pointed to a localization of the viral DNA in 
the superficial parts of the lesion (1), similar to the results 
we show. Therefore, it remains unclear whether cutavirus 
plays a role in the development of CTCL. Recently, Dick-
inson et al. could not detect cutavirus in oropharyngeal and 
oral cavity squamous cell carcinomas (9).
In summary, our data on cutavirus DNA prevalence 
and localization argue against an oncogenic role of cuta-
virus in malignant melanoma. However, oncolytic proper-
ties of this virus or viral hit-and-run oncogenesis cannot 
be excluded (10). Cutavirus seems to be more frequent on 
healthy skin of immunosuppressed patients than on the skin 
of immunocompetent persons and could be part of the hu-
man skin virome. It is possible that cutavirus is an apatho-
genic virus shed from human skin.
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Table. Cutavirus DNA detection and DNA load in cutaneous malignant melanomas, melanoma metastases, and forehead swabs of 




No. cutavirus DNA–positive samples† 
(%; 95% CI) 
Median cutavirus DNA load 
(IQR)‡ 
Malignant melanoma tumor biopsies§¶ 185 2 (1.1; 0.3–3.9) 0.30; 2.82# 
Malignant melanoma metastases§** 52 0 (0; 0–6.9) NA 
Skin swabs of HIV-positive men§ 205 35 (17.1; 12.5–22.8) 0.33 (0.66–3.81) 
Skin swabs of healthy male controls§ 237 9 (3.8; 2.0–7.1) 2.31 (0.19–11.72) 
*Bold type indicates statistical significance. IQR, interquartile range; NA, not applicable.  
†All samples were analyzed with CUTA-UPL5 real-time PCR as described in the Appendix (https://wwwnc.cdc.gov/EID/article/25/8/19-0096-App1.pdf). 
The formalin-fixed paraffin-embedded (FFPE) biopsies (melanomas and metastases) were also analyzed with 2 different real-time PCRs targeting the 
cutavirus nonstructural 1 gene (Appendix). These PCRs did not detect further cutavirus DNA–positive biopsies. 
‡Cutavirus DNA load was determined in all cutavirus DNA–positive samples and was defined as cutavirus DNA copies per -globin gene copy. 
§Details of the biopsies and skin swab specimens are provided in the Appendix. 
¶From 21 cutavirus DNA–negative malignant melanomas, fresh frozen tissue could be analyzed in addition to the FFPE tissue samples (CUTA-UPL5-
PCR). Cutavirus DNA was not detected in any of the 21 fresh frozen tissue samples. The cellular input of the fresh frozen tissue samples ranged from 
1,230 to 40,600 -globin gene copies per 2 L extracted DNA (median 8,330, mean 10,892), indicating a high cellular input. 
#Shown here are the viral DNA loads found in the 2 cutavirus DNA–positive nodular malignant melanomas, MM-A and MM-B. 
**For 6 of the melanoma metastases, the primary tumor was also analyzed and was cutavirus DNA negative. The 2 patients with cutavirus DNA–positive 
melanoma biopsies (MM-A and MM-B) did not have metastatic disease. 
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Monkeypox is a rare viral zoonotic disease; primary infec-
tions are reported from remote forest areas of Central and 
West Africa. We report an investigation of a monkeypox 
outbreak in Lobaye, southwest Central African Republic, in 
October 2018.
Monkeypox, a zoonotic disease caused by an Ortho-poxvirus, has clinical signs and symptoms in humans 
similar to smallpox and a case-fatality rate of 10% (1). The 
specific reservoir species for monkeypox virus remains, to 
a large extent, unidentified (2). Spillover events of mon-
keypox have been reported in remote forest areas of Central 
and West Africa. After zoonotic infection, the virus can be 
transmitted from person to person (1).
To date, human monkeypox outbreaks in the Central Af-
rican Republic (CAR) have been small: ≈10 cases, restricted 
to a family or village. Primary infection in these outbreaks oc-
curred from contact with wild fauna, with secondary transmis-
sion among close contacts in the community (3,4) and limited 
nosocomial transmission (5). Since 2000, the Virology Labo-
ratory of the Institut Pasteur de Bangui (IP Bangui), a regional 
reference center for monkeypox, has reported 20 monkeypox 
outbreaks across several regions of CAR, totaling ≈100 cases, 
particularly in the region of Lobaye (3,4). In 2018 alone, IP 
Bangui investigated 6 different outbreaks in CAR, indicating 
a possible increase in frequency of outbreaks (6,7).
On September 27, 2018, a healthcare worker from Zo-
mea Kaka healthcare center in Lobaye reported to IP Bangui 
about 3 cases of suspected monkeypox in an Aka Pygmy 
family. A 25-year-old female sought care at the health cen-
ter, 10 km from her village, for maculopapular rash and le-
sions. She was afebrile. Her signs and symptoms indicated 
